Table 1.
Demographic and Clinical Variables in Study Participants (N = 40)
| Variable | Median Value (IQR)a |
|---|---|
| Male sex, no. (%) | 40 (100) |
| Age, y | 35.00 (26.50–39.50) |
| EDI to ART, mo | 3.00 (2.50–8.50) |
| Baseline values | |
| Log viral load, log10 copies/ml | 11.34 (10.37–13.30) |
| CD4+ cell count, cells/μl | 485.50 (362.25–649.50) |
| CD4+/CD8+ T-cell ratio, copies/µL | 0.47 (0.32–0.60) |
| CMV DNA copies | |
| Time 1 | 5.19 (2.80–9.58) |
| Time 2 | 3.21 (0.00–5.38) |
| EBV DNA, copies/μL | |
| Time 1 | 83.15 (20.67–247.45) |
| Time 2 | 12.10 (2.14–68.59) |
| Circulating CD4+CX3CR1+ cells, %b | |
| Time 1 | 0.60 (0.38–1.06) |
| Time 2 | 0.66 (0.43–1.06) |
| Circulating CD8+CX3CR1+ cells, %b | |
| Time 1 | 0.61 (0.35–1.22) |
| Time 2 | 0.81 (0.30–1.27) |
Abbreviations: ART, antiretroviral therapy; CMV, cytomegalovirus; EBV, Epstein-Barr virus; EDI, estimated date of infection; IQR, interquartile range.
aData represent median (IQR) values unless otherwise specified.
bCirculating CD4+CX3CR1+ and CD8+CX3CR1+ cell values represent means across subtypes.